par Osowicki, Joshua;Azzopardi, Kristy;Baker, Ciara A;Waddington, Claire S;Pandey, Manisha;Schuster, Tibor;Grobler, Anneke;Cheng, Allen C;Pollard, Andrew John;McCarthy, James J.S.;Good, Michael F;Walker, Mark J;Dale, James B;Batzloff, Michael;Carapetis, Jonathan Rhys;Smeesters, Pierre
;Steer, Andrew C
Référence Vaccine, 37, 26, page (3485-3494)
Publication Publié, 2019-07-01

Référence Vaccine, 37, 26, page (3485-3494)
Publication Publié, 2019-07-01
Article révisé par les pairs
Titre: |
|
Auteur: | Osowicki, Joshua; Azzopardi, Kristy; Baker, Ciara A; Waddington, Claire S; Pandey, Manisha; Schuster, Tibor; Grobler, Anneke; Cheng, Allen C; Pollard, Andrew John; McCarthy, James J.S.; Good, Michael F; Walker, Mark J; Dale, James B; Batzloff, Michael; Carapetis, Jonathan Rhys; Smeesters, Pierre; Steer, Andrew C |
Informations sur la publication: | Vaccine, 37, 26, page (3485-3494) |
Statut de publication: | Publié, 2019-07-01 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Controlled human infection |
Group A Streptococcus | |
Human challenge | |
Human infection studies | |
Streptococcus pyogenes | |
Vaccine development | |
Langue: | Anglais |
Identificateurs: | urn:issn:0264-410X |
info:doi/10.1016/j.vaccine.2019.03.059 | |
info:pii/S0264-410X(19)30405-0 | |
info:scp/85065551948 | |
info:pmid/31101422 |